Hormone treatment in those undergoing transgender transitioning is associated with an increased risk of blood clots.

"There has been recent publicity showing that the use of hormone treatment in those undergoing transgender transitioning is associated with an increased risk of blood clots.

We want to reassure women taking transdermal HRT to treat menopausal symptoms, that there are no increased risks of blood clots to them."

- Dr Louise Newson, Founder, The Menopause Charity and Prof Beverley Hunt, Founder, Thrombosis UK

Award for the Expert Haematology Panel (EHP)

The EHP were pivotal in describing the new condition, vaccine-induced immune thrombocytopenia and thrombosis (VITT), improving survival of patients and preventing further cases, enabling the COVID-19 vaccine programme to continue safely.

Page 1 of 15 Next